Prognomix Inc - Product Pipeline Analysis, 2018 Update

Prognomix Inc - Product Pipeline Analysis, 2018 Update


  • Products Id :- GDME180800PD
  • |
  • Pages: 19
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Prognomix Inc (Prognomix) is a personalized medicine company that develops molecular diagnostic test for detection of risks to develop renal, ocular, cardiac, cerebral, vascular and other complications of diabetic disease. The company's products include PGX IR01, PGx GR01, PGx CD01, PGx IR02. Its PGx CD01 is an in vitro molecular companion diagnostic product used for the treatment of cardiovascular and renal complications of type 2 diabetes. Prognomix's PGX IR01 is an in vitro molecular predictive test used for assessing the risk of complications in patients with type 2 diabetes. The company also develops molecular diagnostic test for detection of risks to develop renal, ocular, cardiac, cerebral, vascular and other complications of diabetic disease. Prognomix is headquartered in Montreal, Quebec, Canada.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Prognomix Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Prognomix Inc Company Overview 4

Prognomix Inc Company Snapshot 4

Prognomix Inc Pipeline Products and Ongoing Clinical Trials Overview 4

Prognomix Inc-Pipeline Analysis Overview 6

Prognomix Inc-Key Facts 6

Prognomix Inc-Major Products and Services 7

Prognomix Inc Pipeline Products by Development Stage 8

Prognomix Inc Pipeline Products Overview 9

PGx CD01 Companion Diagnostic Test 9

PGx CD01 Companion Diagnostic Test Product Overview 9

PGx GR01 10

PGx GR01 Product Overview 10

PGx IR01 11

PGx IR01 Product Overview 11

PGx IR02 12

PGx IR02 Product Overview 12

Prognomix Inc-Key Competitors 13

Prognomix Inc-Key Employees 14

Prognomix Inc-Locations And Subsidiaries 15

Head Office 15

Appendix 16

Methodology 16

About GlobalData 18

Contact Us 18

Disclaimer 19

List of Figures

Prognomix Inc Pipeline Products by Equipment Type 5

Prognomix Inc Pipeline Products by Development Stage 8

List of Tables

Prognomix Inc Pipeline Products and Ongoing Clinical Trials Overview 4

Prognomix Inc Pipeline Products by Equipment Type 5

Prognomix Inc Pipeline Products by Indication 5

Prognomix Inc, Key Facts 6

Prognomix Inc, Major Products and Services 7

Prognomix Inc Number of Pipeline Products by Development Stage 8

Prognomix Inc Pipeline Products Summary by Development Stage 8

PGx CD01 Companion Diagnostic Test-Product Status 9

PGx CD01 Companion Diagnostic Test-Product Description 9

PGx GR01-Product Status 10

PGx GR01-Product Description 10

PGx IR01-Product Status 11

PGx IR01-Product Description 11

PGx IR02-Product Status 12

PGx IR02-Product Description 12

Prognomix Inc, Key Employees 14

Glossary 17

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Canada Diagnostic Centres

KMH Cardiology & Diagnostic Centres, Inc.

Eli Lilly Canada Inc

Prognomix Inc,Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 53925
Site License
USD 1500 INR 107850
Corporate User License
USD 2250 INR 161775

NEWSLETTER BY CATEGORY




Testimonials

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com